← Back to Search

Opioid Use Agreement for Inguinal Hernia

N/A
Waitlist Available
Led By Jonah J Stulberg, MD
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 25-40 days after surgery
Awards & highlights

Study Summary

This trial will test the use of agreements to improve safe opioid use & prevent misuse & opioid-related harm in the acute care setting.

Who is the study for?
Adults at least 18 years old, who speak English or Spanish and are scheduled for general surgery (like bariatric or hernia repair) at selected UT Physicians Health Centers. They must be likely to receive an opioid prescription post-surgery but can't join if they're pregnant, have a known allergy to opioids, cognitive impairments, a history of opioid misuse/abuse, chronic opioid use, or if they've been readmitted before the follow-up.Check my eligibility
What is being tested?
The trial is testing whether safe opioid use agreements between patients and surgical providers can prevent misuse and reduce harm related to opioids after surgery. It's applying practices from chronic pain management into acute care settings where patients receive opioids for short-term pain relief.See study design
What are the potential side effects?
Since this trial involves the implementation of an agreement rather than a drug intervention, there are no direct side effects from medications being tested. However, it aims to mitigate risks associated with opioid use such as addiction or overdose.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~25-40 days after surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and 25-40 days after surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Patient self-reported disposal of prescription opioids
Secondary outcome measures
Disposal method
Opioid pills leftover
Opioid pills used
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Opioid Use AgreementExperimental Treatment1 Intervention
Patients in this group will be administered a safe opioid use agreement by the research coordinator. This agreement is in addition to any routine education and counseling provided by the surgical team.
Group II: Standard of CareActive Control1 Intervention
Patients in this group will receive standard care which includes safe opioid education from the surgical care team.

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center, HoustonLead Sponsor
903 Previous Clinical Trials
320,737 Total Patients Enrolled
Northwestern UniversityOTHER
1,585 Previous Clinical Trials
916,991 Total Patients Enrolled
Jonah J Stulberg, MDPrincipal InvestigatorUTHealth

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there currently vacancies to partake in the experiment?

"The information hosted on clinicaltrials.gov implies that this particular medical trial has stopped the recruitment process. It was originally posted in December 2022 and last updated a year later, however there are currently 557 other studies actively searching for eligible participants."

Answered by AI
~0 spots leftby Apr 2024